The Effects of Tysabri Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis

NCT00536120 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

BIOLOGICAL: BG00002 (natalizumab)
BIOLOGICAL: keyhole limpet hemocyanin (KLH)
BIOLOGICAL: tetanus diphtheria toxoid vaccine (Td)

Sponsor

Biogen